Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Valvular Atrial Fibrillation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06465459
What this trial is testing

Post-marketing Clinical Study of the LAMBRE System for Left Auricle Closure

Who this might be right for
Atrial Fibrillation
French Cardiology Society 220
Not applicableStudy completedNCT03847181
What this trial is testing

Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice

Who this might be right for
Atrial Fibrillation
Bayer 45,164
Not applicableActive Not RecruitingNCT05565599
What this trial is testing

An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Biosense Webster, Inc. 58
Not applicableLooking for participantsNCT07278869
What this trial is testing

Applause Study I - Append System Early Feasibility Study

Who this might be right for
Non Valvular Atrial Fibrillation
Append Medical Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT03433235
What this trial is testing

Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Acute Ischemic Stroke
Jong Sung Kim 68
Not applicableStudy completedNCT02654470
What this trial is testing

Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)

Who this might be right for
Non-valvular Atrial Fibrillation
Boston Scientific Corporation 300
Not applicableStudy completedNCT01774370
What this trial is testing

SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of Korea

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 3,182
Not applicableStudy completedNCT02784717
What this trial is testing

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

Who this might be right for
Stroke
Bayer 3,055
Not applicableUnknownNCT04297150
What this trial is testing

Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

Who this might be right for
Atrial Fibrillation
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 700
Post-approval studies (Phase 4)Ended earlyNCT02561897
What this trial is testing

EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Electrophysiology Research Foundation 5
Not applicableStudy completedNCT01196897
What this trial is testing

Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE)

Who this might be right for
Atrial Fibrillation
Boston Scientific Corporation 69
Not applicableStudy completedNCT03280368
What this trial is testing

Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation

Who this might be right for
Atrial FibrillationMedication AdherenceBlood Coagulation Tests+10 more
Hospitalsenheden Vest 430
Post-approval studies (Phase 4)Study completedNCT02608099
What this trial is testing

Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Baim Institute for Clinical Research 300
Not applicableStudy completedNCT03026556
What this trial is testing

The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database Analysis

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 42,534
Not applicableActive Not RecruitingNCT04676880
What this trial is testing

Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy

Who this might be right for
Atrial FibrillationAnticoagulants and Bleeding Disorders
R&D Cardiologie 609
Not applicableStudy completedNCT02043808
What this trial is testing

The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 25,586
Not applicableWithdrawnNCT03002740
What this trial is testing

Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Bristol-Myers Squibb
Not applicableNot Yet RecruitingNCT07616414
What this trial is testing

Stepwise vs Standard Anticoagulation for AF Patients Undergoing CIED Implantation (STEP-AF)

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)ThromboembolismCardiac Implantable Electronic Device+2 more
Fu Wai Hospital, Beijing, China 424
Testing effectiveness (Phase 2)Study completedNCT00645853
What this trial is testing

Long-term Safety in Atrial Fibrillation Patients

Who this might be right for
Persistent or Permanent Nonvalvular Atrial Fibrillation
AstraZeneca 523
Testing effectiveness (Phase 2)Study completedNCT03489395
What this trial is testing

A Pilot Study on Edoxaban for the Resolution of Left Atrial Thrombosis in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Raffaele De Caterina 25
Next Page